Welcome to LookChem.com Sign In|Join Free
  • or
1-(PYRIDIN-2-YLMETHYL)-1H-PYRAZOL-5-AMINE is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

956779-00-3

Post Buying Request

956779-00-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

956779-00-3 Usage

Chemical structure

A compound consisting of a pyrazol ring fused to a pyridine ring, with an amine group at the 5-position and a methyl group attached to the 2-position of the pyridine ring.

Target

Epidermal growth factor receptor (EGFR) tyrosine kinase

Mechanism of action

Potent and selective inhibitor of EGFR tyrosine kinase, which plays a crucial role in the regulation of cell growth and proliferation.

Therapeutic potential

Extensively studied for its potential as a therapeutic agent in the treatment of various types of cancer, including lung cancer and glioblastoma.

Additional research

Investigated for its role in the modulation of immune responses and inflammatory pathways.

Pharmacological properties

Holds promise for the development of novel targeted therapies for cancer and other diseases.

Check Digit Verification of cas no

The CAS Registry Mumber 956779-00-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,5,6,7,7 and 9 respectively; the second part has 2 digits, 0 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 956779-00:
(8*9)+(7*5)+(6*6)+(5*7)+(4*7)+(3*9)+(2*0)+(1*0)=233
233 % 10 = 3
So 956779-00-3 is a valid CAS Registry Number.

956779-00-3Upstream product

956779-00-3Downstream Products

956779-00-3Relevant academic research and scientific papers

TETRAZOLE COMPOUNDS AS OREXIN RECEPTOR ANTAGONISTS

-

Page/Page column 17, (2011/04/25)

The invention relates to tetrazole compounds of formula (I) wherein X, Y, Z, R1, R2 and R3 are as described in the description; to pharmaceutically acceptable salts thereof, and to the use of such compounds use as medicaments, especially as orexin receptor antagonists.

Approach to the library of fused pyridine-4-carboxylic acids by combes-type reaction of acyl pyruvates and electron-rich amino heterocycles

Volochnyuk, Dmitriy M.,Ryabukhin, Sergey V.,Plaskon, Andrey S.,Dmytriv, Yuri V.,Grygorenko, Oleksandr O.,Mykhailiuk, Pavel K.,Krotko, Dmitriy G.,Pushechnikov, Alexei,Tolmachev, Andrey A.

scheme or table, p. 510 - 517 (2010/09/05)

A library of fused pyridine-4-carboxylic acids (including pyrazolo[3,4-b]pyridines, isoxazolo[5,4-b]pyridines, furo[2,3-b]pyridines, thieno[2,3-b]pyridines, and pyrido[2,3-d]pyrimidines) was generated by Combes-type reaction of acyl pyruvates and electron-rich amino heterocycles followed by hydrolysis of the ester. The library members were also demonstrated to undergo the standard combinatorial transformations including amide coupling and esterification, as well as less common heterocyclizations to 1,2,4-triazoles and 1,2,4-oxadiazoles.

TETRAZOLE COMPOUNDS AS OREXIN RECEPTOR ANTAGONISTS

-

Page/Page column 40, (2010/01/07)

The invention relates to tetrazole compounds of formula (I) wherein X, Y, Z, R1, R2 and R3 are as described in the description; to pharmaceutically acceptable salts thereof, and to the use of such compounds use as medicaments, especially as orexin receptor antagonists.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 956779-00-3